Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Australian Clinical Labs Limited (ASX:ACL) announced the successful passage of all resolutions at its 2024 Annual General Meeting, including the adoption of the remuneration report and the re-election of director Michael Alscher. The renewal of the shareholder-approved LTVR plan also received overwhelming support. Investors can find more details and a recording of the meeting on the company’s website.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.